【24h】

MICRONISATION OF TOBRAMYCIN USING DENSE GAS ANTI-SOLVENT TECHNIQUES

机译:密集气态抗溶剂技术对妥布霉素进行微粉化

获取原文
获取原文并翻译 | 示例

摘要

The feasibility of micronising tobramycin by the gas anti-solvent technique was investigated, The micronisation of tobramycin was carried out by precipitating from a solution using dense gas anti-solvent techniques. Two different techniques, the Gas Anti-Solvent (GAS) method and the Aerosol Solvent Extraction System (ASES) were utilised. Tobramycin was dissolved in an organic solvent such as methanol, ethanol and dimethyl sulfoxide. In the GAS process the solution was expanded with CO_2 at 25℃ and 35℃ with pressures ranging from 50 to 70 bar. In the ASES process the solution was sprayed into a vessel pressurised with carbon dioxide at 25℃ and 45℃ with the density of 0.017 and 0.018 gmol/cm~3. Sub-micron particles of tobramycin were produced using both techniques. The GAS technique produced uniform micro-spheres that had a low degree of agglomeration. The ASES technique produced smaller particles that were highly agglomerated and in some cases, of irregular morphology. The results of in vitro analysis indicated the fine particle mass ( < 5 micron) was at least 40%. It is therefore possible to use the drug for dry powder inhalation delivery.
机译:研究了通过气体反溶剂技术将妥布霉素微粉化的可行性。使用稠密的气体反溶剂技术从溶液中沉淀出妥布霉素以实现微粉化。使用了两种不同的技术,即气体反溶剂(GAS)方法和气溶胶溶剂萃取系统(ASES)。将妥布霉素溶解在有机溶剂如甲醇,乙醇和二甲基亚砜中。在GAS工艺中,溶液在25℃和35℃用CO_2在50至70 bar的压力下膨胀。在ASES工艺中,将溶液喷入25.45°C的二氧化碳加压容器中,密度为0.017和0.018 gmol / cm〜3。两种技术均产生了妥布霉素的亚微米颗粒。 GAS技术产生的团聚度较低的均匀微球。 ASES技术产生的小颗粒高度团聚,在某些情况下还具有不规则的形态。体外分析结果表明,细颗粒质量(<5微米)至少为40%。因此可以将药物用于干粉吸入输送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号